Skip to content

CorMedix CRMD PP&E (Net)

PP&E (Net) at other companies

Pfizer logo
PfizerPFE
$19.4B+5.8%
Merck & Co. logo
Merck & Co.MRK
$25.43B+2.6%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$433.96M+11.2%
ITG
Integer HoldingsITGR
$533.14M+7.5%
IAR
Integra LifeSciencesIART
$446.88M+5.7%
Emergent Biosolutions logo
Emergent BiosolutionsEBS
$199.4M-9.8%

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's PP&E (net)?
CorMedix (CRMD) reported PP&E (net) of $6.17M in Q1 2026.
How has CorMedix's PP&E (net) changed year-over-year?
CorMedix's PP&E (net) increased by 256.8% year-over-year, from $1.73M to $6.17M.
What is the long-term trend for CorMedix's PP&E (net)?
Over 5 years (2020 to 2025), CorMedix's PP&E (net) has grown at a 121.6% compound annual growth rate (CAGR), from $111.5K to $5.96M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.